What To Do About Medicaid? Challenges and Tips for Medtech Innovators


At-home sleep apnea test firm Itamar Medical is making progress with payors, but has hit a barrier with Medicaid for its technology. It’s not an uncommon challenge, say experts, who discuss the challenges and offer advice for medical device innovators dealing with state Medicaid programs.

Israel-based Itamar Medical Ltd. is making market, and payor, inroads with a novel home-based approach to diagnosing sleep apnea, a condition that is increasingly recognized as a major public health threat.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: